Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/171730
PPARa activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background & Aims: Peroxisome proliferator-activated receptor a (PPARa) is a transcription factor activated by ligands that regulates genes related to vascular tone, oxidative stress, and fibrogenesis, pathways implicated in the development of cirrhosis and portal hypertension. This study aims at evaluating the effects of PPARa activation with fenofibrate on hepatic and systemic hemodynamics, hepatic endothelial dysfunction, and hepatic fibrosis in CCl4-cirrhotic rats. Methods: Mean arterial pressure (MAP), portal pressure (PP), and portal blood flow (PBF) were measured in cirrhotic rats treated with oral fenofibrate (25 mg/kg/day, n = 10) or its vehicle (n = 12) for 7 days. The liver was then perfused and dose-relaxation curves to acetylcholine (Ach) were performed. We also evaluated Sirius Red staining of liver sections, collagen-I mRNA expression, and smooth muscle actin (a-SMA) protein expression, cyclo-oxygenase-1 (COX-1) protein expression, and cGMP levels in liver homogenates, and TXB2 production in perfusates. Nitric oxide (NO) bioavailability and eNOS activation were measured in hepatic endothelial cells (HEC) isolated from cirrhotic rat livers. Results: CCl4 cirrhotic rats treated with fenofibrate had a significantly lower PP (29%) and higher MAP than those treated with vehicle. These effects were associated with a significant reduction in hepatic fibrosis and improved vasodilatory response to acetylcholine. Moreover, a reduction in COX-1 expression and TXB2 production in rats receiving fenofibrate and a significant increase in NO bioavailability in HEC with fenofibrate were observed. Conclusions: PPARa activation markedly reduced PP and liver fibrosis and improved hepatic endothelial dysfunction in cirrhotic rats, suggesting it may represent a new therapeutic strategy for portal hypertension in cirrhosis.
Matèries (anglès)
Citació
Citació
RODRÍGUEZ VILARRUPLA, Aina, LAVIÑA SIEMSEN, Bàrbara, GARCÍA CALDERÓ, Héctor, RUSSO, Lucia, ROSADO MATEO, Eugenio, ROGLANS I RIBAS, Núria, BOSCH I GENOVER, Jaume, GARCÍA PAGÁN, Juan carlos. PPARa activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. _Journal of Hepatology_. 2012. Vol. 56, núm. 5, pàgs. 1033-1039. [consulta: 20 de gener de 2026]. ISSN: 0168-8278. [Disponible a: https://hdl.handle.net/2445/171730]